A genetic approach to inactivating chemokine receptors using a modified viral protein

Nature Biotechnology

Volumn 21, Issue 11, 2003, Pages 1321-1327

  McNeil Coffield, V ^a   Jiang, Qi ^a   Su, Lishan ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; BONE; PROTEINS;

GENETIC SYSTEMS;

GENES;

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR4; DEGRAKINE; HYBRID PROTEIN; PROTEASOME; RANTES; RETROVIRUS VECTOR; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; VIRUS PROTEIN; VPU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER THERAPY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; EMBRYO; ENDOPLASMIC RETICULUM; GENE TRANSFER; HEMATOPOIETIC STEM CELL; HOST; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MODIFICATION; STEM CELL;

ANIMALS; CELLS, CULTURED; CHEMOKINES; DRUG DELIVERY SYSTEMS; ENDOPLASMIC RETICULUM; GENE PRODUCTS, VPU; GENE TARGETING; HUMANS; MICE; OSTEITIS; PROTEIN ENGINEERING; RECEPTORS, CHEMOKINE; RECOMBINANT FUSION PROTEINS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; UNIDENTIFIED RETROVIRUS;

EID: 0242290924     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt889     Document Type: Article

References (43)

1. Rossi, D. & Zlotnik, A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18, 217-242 (2000).
2. Yoshie, O., Imai, T. & Nomiyama, H. Chemokines in immunity. Adv. Immunol. 78, 57-110 (2001).
3. Sallusto, F., Mackay, C.R. & Lanzavecchia, A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18, 593-620 (2000).
4. Nelson, P.J. & Krensky, A.M. Chemokines, chemokine receptors, and allograft rejection. Immunity 14, 377-386 (2001).
5. Baggiolini, M. Chemokines and leukocyte traffic. Nature 392, 565-568 (1998).
6. + intraepithelial lymphocyte compartment. Eur. J. Immunol. 32, 3488-3497 (2002).
7. Chen, J.D., Bai, X., Yang, A.G., Cong, Y. & Chen, S.Y. Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy. Nat. Med. 3, 1110-1116 (1997).
8. Engel, B.C. et al. Intrakines-evidence for a trans-cellular mechanism of action. Mol. Ther. 1, 165-170 (2000).
9. McManus, M.T. et al. Small interfering RNA-mediated gene silencing in T lymphocytes. J. Immunol. 169, 5754-5760 (2002).
10. McManus, M.T. & Sharp, P.A. Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 3, 737-747 (2002).
11. Cullen, B.R. RNA interference: antiviral defense and genetic tool. Nat. Immunol. 3, 597-599 (2002).
12. Brummelkamp, T.R., Bernards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553 (2002).
13. Tiscornia, G., Singer, O., Ikawa, M. & Verma, I.M. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl. Acad. Sci. USA 27, 27 (2003).
14. Tortorella, D., Gewurz, B.E., Furman, M.H., Schust, D.J. & Ploegh, H.L. Viral subversion of the immune system. Annu. Rev. Immunol. 18, 861-926 (2000).
15. Hirsch, C. & Ploegh, H.L. Intracellular targeting of the proteasome. Trends Cell Biol. 10, 268-272 (2000).
16. Margottin, F. et al. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell. 1, 565-574 (1998).
17. Willey, R.L., Maldarelli, F., Martin, M.A. & Strebel, K. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 66, 7193-7200 (1992).
18. Schubert, U. & Strebel, K. Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J. Virol. 68, 2260-2271 (1994).
19. Loetscher, M. et al. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J. Biol. Chem. 269, 232-237 (1994).
20. Bleul, C.C. et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829-833 (1996).
21. Bleul, C.C., Fuhlbrigge, R.C., Casasnovas, J.M., Aiuti, A. & Springer, T.A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184, 1101-1109 (1996).
22. Oberlin, E. et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382, 833-835 (1996).
23. Shirozu, M. et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 28, 495-500 (1995).
24. Tashiro, K. et al. Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 261, 600-603 (1993).
25. Nagasawa, T. et al. Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin. Proc. Natl. Acad. Sci. USA 93, 14726-14729 (1996).
26. + progenitors to peripheral blood. J. Exp. Med. 185, 111-120 (1997).
27. Zou, Y.R., Kottmann, A.H., Kuroda, M., Taniuchi, I. & Littman, D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393, 595-599 (1998).
28. Kawabata, K. et al. A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution. Proc. Natl. Acad. Sci. USA 96, 5663-5667 (1999).
29. Peled, A. et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283, 845-848 (1999).
30. D'Apuzzo, M. et al. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. Eur. J. Immunol. 27, 1788-1793 (1997).
31. Schols, D. et al. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J. Exp. Med. 186, 1383-1388 (1997).
32. low thymocytes. Blood 94, 1890-1898 (1999).
33. Kim, C.H. & Broxmeyer, H.E. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood 91, 100-110 (1998).
34. Wright, D.E., Bowman, E.P., Wagers, A.J., Butcher, E.C. & Weissman, I.L. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J. Exp. Med. 195, 1145-1154 (2002).
35. Spangrude, G.J., Heimfeld, S. & Weissman, I.L. Purification and characterization of mouse hematopoietic stem cells. Science 241, 58-62 (1988).
36. Hardy, J. et al. Bioluminescence imaging of lymphocyte trafficking in vivo. Exp. Hematol. 29, 1353-1360 (2001).
37. Contag, P.R., Olomu, I.N., Stevenson, D.K. & Contag, C.H. Bioluminescent indicators in living mammals. Nat. Med. 4, 245-247 (1998).
38. Cheng, L. et al. Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lympho-myeloid progeny. Blood 92, 83-92 (1998).
39. Pear, W.S., Nolan, G.P., Scott, M.L. & Baltimore, D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392-8396 (1993).
40. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63 (1983).
41. Vilen, B.J., Burke, K.M., Sleater, M. & Cambier, J.C. Transmodulation of BCR signaling by transduction-incompetent antigen receptors: implications for impaired signaling in anergic B cells. J. Immunol. 168, 4344-4351 (2002).
42. Lapham, C.K., Zaitseva, M.B., Lee, S., Romanstseva, T. & Golding, H. Fusion of monocyctes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5. Nature 5, 303-308 (1999).
43. Szilvassy, S.J., Meyerrose, T.E., Ragland, P.L. & Grimes, B. Differential homing and engraftment properties of hematopoietic progenitor cells from murine bone marrow, mobilized peripheral blood, and fetal liver. Blood 98, 2108-2115 (2001).